Product Description: SDZ NVI 085 is a compound with CNS stimulatory effects, primarily through the α1-adrenoceptor subtype, with anti-cataplexy and anti-stroke activities. SDZ NVI 085 also has a significant alertness effect and can be used to study other types of excessive sleepiness[1].
Formula: C15H21NO2S
References: [1]A Renaud, et al. Effects of SDZ NVI-085, a putative subtype-selective α1-agonist, on canine cataplexy, a disorder of rapid eye movement sleep. European journal of pharmacology 205.1 (1991): 11-16.
CAS Number: 104195-17-7
Molecular Weight: 279.40
Research Area: Neurological Disease
Target: Adrenergic Receptor